share_log

和黃醫藥：截至2024年5月31日止月份之股份發行人的證券變動月報表

HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended May 31, 2024

Hong Kong Stock Exchange ·  Jun 3 16:44
Summary by Futu AI
和黃醫藥（中國）有限公司於2024年6月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年5月31日的公司股本變動情況。報告顯示，和黃醫藥的法定/註冊股本及已發行股份在該月份內保持不變，總數為1,500,000,000股，每股面值0.1美元，總股本為1億5千萬美元。此外，根據2015年4月24日通過的股份期權計劃，本月內有8,550股新股份因行使股份期權而發行，並獲得18,382.5美元的資金。報告亦確認，所有新發行的證券均已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
和黃醫藥（中國）有限公司於2024年6月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年5月31日的公司股本變動情況。報告顯示，和黃醫藥的法定/註冊股本及已發行股份在該月份內保持不變，總數為1,500,000,000股，每股面值0.1美元，總股本為1億5千萬美元。此外，根據2015年4月24日通過的股份期權計劃，本月內有8,550股新股份因行使股份期權而發行，並獲得18,382.5美元的資金。報告亦確認，所有新發行的證券均已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
On June 3, 2024, Hutchmed (China) Limited submitted the latest monthly securities variation report to Hong Kong Exchanges and Clearing Limited, reporting the company's capital changes as of May 31, 2024. The report shows that Hutchmed's legal/registered share capital and issued shares remained the same during the month, with a total of 1,500,000,000 shares and a par value of $0.1 per share, making the total capital $150 million. In addition, 8,550 new shares were issued this month due to the exercise of stock options under the share option plan approved on April 24, 2015, and raised $18,382.5. The report also confirms that all newly issued securities have received formal authorization from the board of directors and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.
On June 3, 2024, Hutchmed (China) Limited submitted the latest monthly securities variation report to Hong Kong Exchanges and Clearing Limited, reporting the company's capital changes as of May 31, 2024. The report shows that Hutchmed's legal/registered share capital and issued shares remained the same during the month, with a total of 1,500,000,000 shares and a par value of $0.1 per share, making the total capital $150 million. In addition, 8,550 new shares were issued this month due to the exercise of stock options under the share option plan approved on April 24, 2015, and raised $18,382.5. The report also confirms that all newly issued securities have received formal authorization from the board of directors and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.